Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002
Emerging Patterns of Diffusion-Weighted MR Imaging in Creutzfeldt-Jakob Disease: Case Report and Review of the Literature
AJNR 23:550-556, Mao-Draayer,Y.,et al, 2002
Therapy for the Epilepsies
Arch Neurol 59:732-735, Van Ness,P.C., 2002
Treatment of Spinal Epidural Metastasis Improves Patient Survival and Functional State
Neurol 58:1360-1366, Zaidat,O.O &Ruff,R.L., 2002
Therapies for Movement Disorders
Arch Neurol 59:699-702, Goetz,C.G &Hinson,V.K., 2002
Friedreich Ataxia
Arch Neurol 59:743-747, Lynch,D.R.,et al, 2002
Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002
Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002
Emergency Craniotomy in Patients Worsening Due to Expanded Cerebral Hematoma
Neurol 58:1367-1372,1325, Rabinstein,A.A.,et al, 2002
Treatment Interventions for Parkinson's Disease: An Evidence Based Assessment
Lancet 359:1589-1598, Rascol,O.,et al, 2002
Gluten Sensitivity as a Neurological Illness
JNNP 72:560-563, Hadjivassiliou,M.,et al, 2002
Computed Tomographic Findings in Patients Undergoing Intra-arterial Thrombolysis for Acute Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Stroke 33:1557-1567, Roberts,H.C.,et al, 2002
Multidisciplinary Management of Spinal Dural Arteriovenous Fistulas
Stroke 33:1578-1583, van Dijk,J.M.C.,et al, 2002
Use of Intravenous Heparin by North American Neurologists
Stroke 33:1574-1577, Al-Sadat,A.,et al, 2002
Prognostic Importance of Leukoaraiosis in Patients with Symptomatic Internal Carotid Artery Stenosis
Stroke 33:1651-1655, Streifler,J.Y.,et al, 2002
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Temporal Arteritis
JAMA 287:2996-3000,3034, Hellmann,D.B., 2002
Utility of Clinical Criteria in Differentiating Frontotemporal Lobar Degeneration (FTLD) From AD
Neurol 58:1608-1615, Rosen,H.J.,et al, 2002
Thalamic Venous Infarction as a Cause of Subacute Dementia
Neurol 58:1689-1691, Krolak-Salmon,P.,et al, 2002
A Randomized Trial of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis
Neurol 58:1652-1659, Freitag,F.G.,et al, 2002
Posterior Reversible Encephalopathy Syndrome: Prognostic Utility of Quantitative Diffusion-Weighted MR Images
AJNR 23:1038-1048, Covarrubias,D.J.,et al, 2002
High-dose Cyclophosphamide Without Stem-cell Rescue for Refractory CIDP
Neurol 58:1856-1858, Brannagan,T.H.,et al, 2002
Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002
Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002
Nanging
Lancet 360:384, Ng, J. &Frith, R., 2002
Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002
Anthrax meningoencephalitis
Neurol 59:327-334,300, Lanska,D.J., 2002
Conspicuity and Evolution of Lesions in Creutzfeldt-Jakob Disease at Diffusion-Weighted Imaging
AJNR 23:1164-1172,1070, Murata,T.,et al, 2002
Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity After a Stroke
NEJM 347:385-394,382, Brashear,A.,et al, 2002
Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients
Stroke 33:2025-2031, Wintermark,M.,et al, 2002
The Final Month of Life in Patients with ALS
Neurol 59:428-431, Ganzini,L.,et al, 2002
Normalization of T2 Signal Abnormalities in Hemispheric White Matter with Liver Transplant
Neurol 59:335-341, Rovira,A.,et al, 2002
Dermoid Inclusion Cysts and Early Spinal Cord Tethering After Fetal Surgery for Myelomeningocele
NEJM 347:256-259,230, Mazzola,C.A.,et al, 2002
Reversible Chorea and Focal Dystonia in Vitamin B12 Deficiency
NEJM 347:295, Pacchetti,C.,et al, 2002
Polymyalgia Rheumatica and Giant-Cell Arteritis
NEJM 347:261-271, Salvarani,C.,et al, 2002
Diffusion-Weighted MR Imaging in the Acute Phase of Transient Ischemic Attacks
AJNR 23:77-83,4, Rovira,A.,et al, 2002
Steroid Treatment for Myasthenia Gravis
Muscle Nerve 25:115-121, Rivner,M.H., 2002
Carpal Tunnel Syndrome
NEJM 346:1807-1812, Katz,J.N &Simmons,B.P., 2002
Central Nervous System Infection in Congenital Syphilis
NEJM 346:1792-1798, Michelow,I.C.,et al, 2002
Donepezil for Cognitive Impairment in Parkinson's Disease: A Randomised Controlled Study
JNNP 72:708-712, Aarsland,D.,et al, 2002
A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002
First-line Therapy with Temozolomide Induces Regression of Primary CNS Lymphoma
Neurol 58:1573-1574, Herrlinger,U.,et al, 2002
Acute Basilar Artery Occlusion Treated with Combined Intravenous Abciximab and Intra-arterial Tissue Plaminogen Activator
Stroke 33:1424-1427, Eckert,B.,et al, 2002
Mannitol in Acute Traumatic Brain Injury
Lancet 359:1633-1634, Schrot,R.J. &Muizelaar,J.P., 2002
Euthanasia and Physician-Assisted Suicide Among Patients with Amyotrophic Lateral Sclerosis in the Netherlands
NEJM 346:1638-1644, Veldink,J.H.,et al, 2002
Diffuse Metabolic Abnormalities in Reversible Posterior Leukoencephalopathy Syndrome
AJNR 23:833-837, Eichler,F.S.,et al, 2002
Intravenous Immunoglobulin for Dysphagia of Inclusion Body Myositis
Neurol 58:326-327, Cherin,P.,et al, 2002
Correlation of Diffusion-Weighted Magnetic Resonance Imaging With Neuropathology in Creutzfeldt-Jakob Disease
Arch Neurol 59:128-134, Mittal,S.,et al, 2002
Diffusion-Weighted Imaging Abnormalities in Wernicke Encephalopathy
Arch Neurol 59:123-127, Chu,K.,et al, 2002
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
Arch Neurol 59:43-46,29, Lopez,O.L,et al, 2002